indazoles has been researched along with gdc 0449 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hussar, DA | 1 |
Dintsios, CM; Rasch, A | 1 |
Chougnet, C; Goldwirt, L; Huynh, HH; Le Maignan, C; Madelaine, I; Mourah, S; Plé, A; Pressiat, C; Sauvageon, H | 1 |
1 review(s) available for indazoles and gdc 0449
Article | Year |
---|---|
[Subgroups in the early benefit assessment of pharmaceuticals: a methodical review].
Topics: Adenosine; Anilides; Axitinib; Drug Approval; Effect Modifier, Epidemiologic; Fingolimod Hydrochloride; Germany; Humans; Imidazoles; Indazoles; National Health Programs; Pyridines; Risk Assessment; Sitagliptin Phosphate; Sofosbuvir; Ticagrelor | 2015 |
2 other study(ies) available for indazoles and gdc 0449
Article | Year |
---|---|
New drugs 2013, Part I.
Topics: Aminophenols; Anilides; Antibodies, Monoclonal, Humanized; Axitinib; Benzodiazepines; Carbamates; Clobazam; Diterpenes; Drug Approval; gamma-Glutamyl Hydrolase; Glucosylceramidase; Humans; Imidazoles; Indans; Indazoles; Peptides; Phenylenediamines; Prostaglandins F; Pyridines; Quinolones | 2013 |
Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Topics: Angiogenesis Inhibitors; Anilides; Chromatography, Liquid; Humans; Indazoles; Nitriles; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Reproducibility of Results; Sulfonamides; Tandem Mass Spectrometry | 2018 |